Program Description: 
This is a monthly Grand Rounds to help educate our Urology Faculty, Residents, Allied Healthcare Providers, and Community Physicians.  It is designed around Urologic topics to assist in updated medical topics and care.
 
Provide timely updated education to a wide spectrum on current urologic topics and controversies. The information provided by our speakers is intended to enhance basic knowledge on fundamental principles in urology and broaden the scope of knowledge on more focused topics. Speakers and topics are chosen based upon their relevance to current needs put forth by the audience as well as updates to current guidelines and controversies.
 
Adult Urologic disease cover a broad spectrum of topics, which are treatmed by a wide assortment of providers. Staying current on a variety of changing controversies and refreshing knowledge on core competencies is critical to maintaining an excellence in care. Additionally, our grand rounds help to educate and train our residents and broaden their educational exposure.
 
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
AMA Credit Designation:
The Medical College of Wisconsin designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Hours of Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
 
Target audience: 
  • Urology Faculty
  • Residents
  • Allied Healthcare Providers
  • Community Physicians
Learning objectives: 

At the conclusion of this activity, I will be able to:

  1. Participants will understand basic principles or immunology and strategies for cancer immunotherapy.
  2. Participants will be able to identify patients who are candidates for cancer immunotherapy treatment.
  3. Participants will recognize the value of emerging immunotherapies in the treatment of GU malignancies.

 

 

Faculty & credentials: 

Name:

Role in Meeting:

Ken Jacobsohn, MD

Planning Committee

William See, MD

Planning Committee

Jonathan Treisman, MD, FACP

Guest Speakers

All persons in control of content have no relevant financial relationships to disclose with the exception of the following person:

Jonathan Treisman, MD, FACP has commerical interest as a speaker and advisory board member with Prometheus Laboratories and advisory board member with Bristol Myers Squibb.

In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships.  These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

 

 

Contact

Name: 
Tammy Janik
Phone number: 
+1 (414) 805-0788
Email: 
tjanik@mcw.edu
Session date: 
12/04/2015 - 7:30am to 8:30am CST
Location: 
Zablocki VA Medical Center in Auditorium
5000 W National Avenue
Milwaukee, WI
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.